• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    9/15/23 11:52:24 AM ET
    $PLNT
    $PLRX
    $PMF
    $PML
    Hotels/Resorts
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $PLNT alert in real time by email

     

    Friday's session saw 169 companies set new 52-week lows.

    Points of Interest From Today's 52-Week Lows:

    • Bristol-Myers Squibb (NYSE:BMY) was the largest firm by market cap to set a new 52-week low.
    • Blue Star Foods (NASDAQ:BSFC) was the smallest company in terms of market cap to set a new 52-week low.
    • PTC Therapeutics (NASDAQ:PTCT)'s stock fell the most, as it traded down 31.29% to reach a new 52-week low.
    • Prelude Therapeutics (NASDAQ:PRLD)'s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.

    On Friday, the following stocks set new 52-week lows:

    • Bristol-Myers Squibb (NYSE:BMY) stock dropped to a yearly low on Friday of $58.92. Shares traded down 0.87%.
    • Realty Income (NYSE:O) shares reached a new 52-week low of $54.29 on Friday morning, moving down 1.42%.
    • Illumina (NASDAQ:ILMN) stock hit a yearly low of $145.14. The stock was down 3.41% for the day.
    • ResMed (NYSE:RMD) stock hit $145.74 on Friday morning, setting a new 52-week low for a change of down 0.98%.
    • Royalty Pharma (NASDAQ:RPRX) shares made a new 52-week low of $28.21 on Friday. The stock was down 1.67% for the day.
    • Insulet (NASDAQ:PODD) stock hit $166.03 on Friday morning, setting a new 52-week low for a change of down 3.92%.
    • Chewy (NYSE:CHWY) stock set a new 52-week low of $20.48 on Friday, moving down 2.75%.
    • TKO Group Holdings (NYSE:TKO) shares fell to $99.24 on Friday, setting a new 52-week low with a shift of down 1.27%.
    • SolarEdge Technologies (NASDAQ:SEDG) stock hit a new 52-week low of $141.67. The stock was down 1.29% on the session.
    • Liberty SiriusXM Gr (NASDAQ:LSXMB) shares reached a new 52-week low of $22.19 on Friday morning, moving down 3.38%.
    • Agree Realty (NYSE:ADC) shares set a new 52-week low of $59.51. The stock traded down 0.9%.
    • Envista Holdings (NYSE:NVST) shares made a new 52-week low of $28.74 on Friday. The stock was down 0.62% for the day.
    • Planet Fitness (NYSE:PLNT) stock dropped to a yearly low on Friday of $50.21. Shares traded down 15.17%.
    • Cava Group (NYSE:CAVA) stock broke to a new 52-week low of $34.42 on Friday. Shares of the company traded down 3.66%.
    • Medical Properties Trust (NYSE:MPW) stock achieved a new 52-week low on Friday morning, hitting $6.28 and moving down 3.72%.
    • PNM Resources (NYSE:PNM) stock broke to a new 52-week low of $43.64 on Friday. Shares of the company traded down 0.22%.
    • Savers Value Village (NYSE:SVV) shares fell to $19.61 on Friday, setting a new 52-week low with a shift of down 2.02%.
    • Physicians Realty Trust (NYSE:DOC) shares hit a yearly low of $12.94. The stock was down 3.03% on the session.
    • Macy's (NYSE:M) stock hit $11.15 on Friday morning, setting a new 52-week low for a change of down 1.54%.
    • Tower Semiconductor (NASDAQ:TSEM) stock dropped to a yearly low on Friday of $27.23. Shares traded down 2.22%.
    • Galapagos (NASDAQ:GLPG) stock dropped to a yearly low on Friday of $36.00. Shares traded down 0.11%.
    • PTC Therapeutics (NASDAQ:PTCT) shares set a new yearly low of $24.43 this morning. The stock was down 31.29% on the session.
    • Grupo Televisa (NYSE:TV) stock set a new 52-week low of $3.41 on Friday, moving down 2.01%.
    • Mister Car Wash (NYSE:MCW) shares hit a yearly low of $6.04. The stock was down 1.61% on the session.
    • Peloton Interactive (NASDAQ:PTON) shares hit a yearly low of $4.96. The stock was down 2.43% on the session.
    • Spirit AeroSystems Hldgs (NYSE:SPR) shares were up 1.28% for the day, having made a 52-week low of $16.28.
    • Silicon Motion Technology (NASDAQ:SIMO) shares set a new 52-week low of $50.51. The stock traded down 1.35%.
    • Supernus Pharmaceuticals (NASDAQ:SUPN) shares set a new 52-week low of $28.77. The stock traded down 1.13%.
    • ZIM Integrated Shipping (NYSE:ZIM) shares set a new yearly low of $11.15 this morning. The stock was up 0.45% on the session.
    • Amylyx Pharma (NASDAQ:AMLX) shares set a new yearly low of $19.36 this morning. The stock was up 0.25% on the session.
    • Petco Health and Wellness (NASDAQ:WOOF) stock drifted down 3.78% on Friday morning to hit a new 52-week low of $4.44.
    • Syndax Pharmaceuticals (NASDAQ:SNDX) stock hit a yearly low of $16.76. The stock was down 0.21% for the day.
    • Netstreit (NYSE:NTST) stock broke to a new 52-week low of $16.62 on Friday. Shares of the company traded up 0.3%.
    • Phreesia (NYSE:PHR) stock hit a new 52-week low of $19.52. The stock was down 1.44% on the session.
    • Pliant Therapeutics (NASDAQ:PLRX) shares reached a new 52-week low of $15.82 on Friday morning, moving down 0.56%.
    • Olo (NYSE:OLO) shares set a new 52-week low of $5.63. The stock traded down 0.44%.
    • Definitive Healthcare (NASDAQ:DH) stock set a new 52-week low of $8.07 on Friday, moving down 1.21%.
    • Tekla Healthcare (NYSE:HQH) stock set a new 52-week low of $15.96 on Friday, moving down 0.68%.
    • GDEV (NASDAQ:GDEV) stock achieved a new 52-week low on Friday morning, hitting $3.09 and moving down 9.33%.
    • Gogoro (NASDAQ:GGR) stock drifted down 0.55% on Friday morning to hit a new 52-week low of $2.67.
    • Silk Road Medical (NASDAQ:SILK) stock broke to a new 52-week low of $16.72 on Friday. Shares of the company traded down 1.52%.
    • DocGo (NASDAQ:DCGO) stock drifted down 5.11% on Friday morning to hit a new 52-week low of $5.76.
    • PIMCO Income Strategy (NYSE:PFN) stock broke to a new 52-week low of $6.63 on Friday. Shares of the company traded up 0.15%.
    • FuelCell Energy (NASDAQ:FCEL) stock broke to a new 52-week low of $1.23 on Friday. Shares of the company traded down 3.02%.
    • PIMCO Municipal Income (NYSE:PML) stock achieved a new 52-week low on Friday morning, hitting $8.28 and moving up 0.35%.
    • Nuveen California (NYSE:NKX) stock hit $10.71 on Friday morning, setting a new 52-week low for a change of down 0.28%.
    • Consensus Cloud Solutions (NASDAQ:CCSI) shares set a new yearly low of $25.05 this morning. The stock was down 2.26% on the session.
    • Theravance Biopharma (NASDAQ:TBPH) shares set a new yearly low of $9.05 this morning. The stock was down 5.77% on the session.
    • Lyell Immunopharma (NASDAQ:LYEL) stock set a new 52-week low of $1.66 on Friday, moving down 1.72%.
    • Perfect (NYSE:PERF) stock dropped to a yearly low on Friday of $3.21. Shares traded down 7.28%.
    • Seres Therapeutics (NASDAQ:MCRB) shares moved down 2.2% on Friday to hit a new 52-week low of $2.83, drifting down 2.2%.
    • Eaton Vance Municipal IT (NYSE:EVN) stock hit a yearly low of $9.26. The stock was up 0.22% for the day.
    • Butterfly Network (NYSE:BFLY) shares set a new yearly low of $1.61 this morning. The stock was up 8.57% on the session.
    • Aerovate Therapeutics (NASDAQ:AVTE) stock broke to a new 52-week low of $12.87 on Friday. Shares of the company traded down 5.14%.
    • Materialise (NASDAQ:MTLS) shares fell to $5.96 on Friday, setting a new 52-week low with a shift of down 1.32%.
    • QuantaSing Group (NASDAQ:QSG) shares were down 5.76% for the day, having made a 52-week low of $5.70.
    • TH International (NASDAQ:THCH) stock hit a yearly low of $1.93. The stock was down 2.99% for the day.
    • Expensify (NASDAQ:EXFY) stock set a new 52-week low of $3.56 on Friday, moving down 3.81%.
    • Nuvation Bio (NYSE:NUVB) shares were down 2.17% for the day, having made a 52-week low of $1.33.
    • SkyWater Technology (NASDAQ:SKYT) stock hit a yearly low of $6.06. The stock was down 1.77% for the day.
    • Nuveen Core Plus Impact (NYSE:NPCT) stock hit a new 52-week low of $9.51. The stock was down 0.15% on the session.
    • Citizens Financial Servs (NASDAQ:CZFS) stock broke to a new 52-week low of $49.69 on Friday. Shares of the company traded down 0.14%.
    • PIMCO Municipal Income (NYSE:PMF) shares hit a yearly low of $8.92. The stock was down 0.22% on the session.
    • Axogen (NASDAQ:AXGN) shares made a new 52-week low of $5.30 on Friday. The stock was down 2.44% for the day.
    • Fate Therapeutics (NASDAQ:FATE) shares set a new yearly low of $2.28 this morning. The stock was down 2.54% on the session.
    • Cambium Networks (NASDAQ:CMBM) shares made a new 52-week low of $7.43 on Friday. The stock was down 2.86% for the day.
    • Gossamer Bio (NASDAQ:GOSS) stock broke to a new 52-week low of $0.84 on Friday. Shares of the company traded down 1.68%.
    • eGain (NASDAQ:EGAN) shares set a new yearly low of $5.80 this morning. The stock was down 4.13% on the session.
    • Blackrock Investment (NYSE:BKN) shares hit a yearly low of $10.61. The stock was down 0.38% on the session.
    • SIGNA Sports United (NYSE:SSU) shares moved down 6.3% on Friday to hit a new 52-week low of $0.45, drifting down 6.3%.
    • PIMCO CA Muni Income Fund (NYSE:PCK) shares hit a yearly low of $5.44. The stock was down 0.7% on the session.
    • Prelude Therapeutics (NASDAQ:PRLD) stock drifted 0.0% (flat) on Friday morning to hit a new 52-week low of $3.07.
    • CoreCard (NYSE:CCRD) shares set a new yearly low of $20.01 this morning. The stock was down 0.74% on the session.
    • XIAO-I (NASDAQ:AIXI) shares fell to $2.17 on Friday, setting a new 52-week low with a shift of down 2.01%.
    • Gabelli Healthcare (NYSE:GRX) shares set a new yearly low of $9.10 this morning. The stock was down 0.22% on the session.
    • Skillz (NYSE:SKLZ) stock dropped to a yearly low on Friday of $6.32. Shares traded down 0.93%.
    • Zentek (NASDAQ:ZTEK) stock dropped to a yearly low on Friday of $1.19. Shares traded up 3.23%.
    • Lazydays Hldgs (NASDAQ:LAZY) shares set a new yearly low of $9.13 this morning. The stock was down 8.46% on the session.
    • Flaherty & Crumrine Prefd (NYSE:PFD) stock achieved a new 52-week low on Friday morning, hitting $9.41 and moving up 0.53%.
    • China Automotive Systems (NASDAQ:CAAS) stock drifted down 3.09% on Friday morning to hit a new 52-week low of $3.67.
    • NGM Biopharmaceuticals (NASDAQ:NGM) stock dropped to a yearly low on Friday of $1.29. Shares traded up 2.29%.
    • Honest Co (NASDAQ:HNST) stock hit $1.11 on Friday morning, setting a new 52-week low for a change of down 15.6%.
    • ContextLogic (NASDAQ:WISH) shares fell to $4.44 on Friday, setting a new 52-week low with a shift of down 1.74%.
    • Vacasa (NASDAQ:VCSA) stock broke to a new 52-week low of $0.40 on Friday. Shares of the company traded up 1.26%.
    • BioAtla (NASDAQ:BCAB) shares reached a new 52-week low of $2.03 on Friday morning, moving up 0.49%.
    • Sezzle (NASDAQ:SEZL) shares hit a yearly low of $14.01. The stock was down 7.2% on the session.
    • FibroGen (NASDAQ:FGEN) shares set a new yearly low of $0.88 this morning. The stock was down 2.54% on the session.
    • OFS Credit Co (NASDAQ:OCCI) shares made a new 52-week low of $7.26 on Friday. The stock was down 0.71% for the day.
    • GABELLI CONVERTIBLE (NYSE:GCV) shares made a new 52-week low of $3.73 on Friday. The stock was up 0.53% for the day.
    • Clene (NASDAQ:CLNN) shares made a new 52-week low of $0.56 on Friday. The stock was down 5.51% for the day.
    • Rani Therapeutics Hldgs (NASDAQ:RANI) shares fell to $2.80 on Friday, setting a new 52-week low with a shift of down 4.11%.
    • Spectral AI (NASDAQ:MDAI) shares were down 6.3% for the day, having made a 52-week low of $3.60.
    • Zapp Electric Vehicles (NASDAQ:ZAPP) stock hit a yearly low of $1.22. The stock was down 6.15% for the day.
    • Personalis (NASDAQ:PSNL) shares set a new 52-week low of $1.37. The stock traded down 0.77%.
    • Sol-Gel Technologies (NASDAQ:SLGL) stock set a new 52-week low of $2.16 on Friday, moving down 0.4%.
    • GEN Restaurant Gr (NASDAQ:GENK) shares made a new 52-week low of $12.59 on Friday. The stock was down 3.55% for the day.
    • Eargo (NASDAQ:EAR) stock hit a new 52-week low of $2.44. The stock was up 0.81% on the session.
    • Mira Pharmaceuticals (NASDAQ:MIRA) stock achieved a new 52-week low on Friday morning, hitting $3.41 and moving down 3.94%.
    • Brainstorm Cell (NASDAQ:BCLI) stock hit a yearly low of $0.95. The stock was down 5.0% for the day.
    • Lantern Pharma (NASDAQ:LTRN) shares set a new 52-week low of $4.00. The stock traded down 3.94%.
    • Prestige Wealth (NASDAQ:PWM) stock broke to a new 52-week low of $4.50 on Friday. Shares of the company traded down 4.88%.
    • Leap Therapeutics (NASDAQ:LPTX) stock hit a yearly low of $1.60. The stock was down 2.12% for the day.
    • Liberty TripAdvisor Hldgs (NASDAQ:LTRPA) shares were down 1.68% for the day, having made a 52-week low of $0.52.
    • Brilliant Earth Group (NASDAQ:BRLT) stock hit a yearly low of $3.07. The stock was down 2.82% for the day.
    • Enlivex Therapeutics (NASDAQ:ENLV) shares reached a new 52-week low of $1.72 on Friday morning, moving down 4.77%.
    • PIMCO New York Municipal (NYSE:PYN) stock achieved a new 52-week low on Friday morning, hitting $5.67 and moving up 0.18%.
    • Solowin Holdings (NASDAQ:SWIN) stock hit a new 52-week low of $2.27. The stock was down 10.04% on the session.
    • Koss (NASDAQ:KOSS) stock broke to a new 52-week low of $3.35 on Friday. Shares of the company traded down 2.31%.
    • RF Industries (NASDAQ:RFIL) shares hit a yearly low of $2.92. The stock was down 18.11% on the session.
    • SEALSQ (NASDAQ:LAES) shares fell to $3.05 on Friday, setting a new 52-week low with a shift of down 6.39%.
    • Sunworks (NASDAQ:SUNW) stock broke to a new 52-week low of $0.68 on Friday. Shares of the company traded down 3.48%.
    • IN8bio (NASDAQ:INAB) shares were down 0.53% for the day, having made a 52-week low of $0.90.
    • OncoCyte (NASDAQ:OCX) shares set a new 52-week low of $3.18. The stock traded up 2.13%.
    • Alpine 4 Holdings (NASDAQ:ALPP) stock set a new 52-week low of $0.91 on Friday, moving down 2.79%.
    • VBI Vaccines (NASDAQ:VBIV) stock set a new 52-week low of $1.01 on Friday, moving down 2.75%.
    • Protara Therapeutics (NASDAQ:TARA) shares set a new 52-week low of $2.05. The stock traded down 0.45%.
    • Cyngn (NASDAQ:CYN) shares made a new 52-week low of $0.50 on Friday. The stock was down 7.89% for the day.
    • Phoenix New Media (NYSE:FENG) shares reached a new 52-week low of $1.12 on Friday morning, moving down 0.83%.
    • Vaccinex (NASDAQ:VCNX) shares set a new 52-week low of $0.17. The stock traded down 8.97%.
    • EZGO Technologies (NASDAQ:EZGO) shares reached a new 52-week low of $0.16 on Friday morning, moving down 3.61%.
    • PolyPid (NASDAQ:PYPD) shares fell to $0.24 on Friday, setting a new 52-week low with a shift of down 7.49%.
    • Intrusion (NASDAQ:INTZ) stock achieved a new 52-week low on Friday morning, hitting $0.50 and moving down 4.61%.
    • Talis Biomedical (NASDAQ:TLIS) shares hit a yearly low of $5.79. The stock was down 4.99% on the session.
    • Remark Hldgs (NASDAQ:MARK) shares moved down 1.59% on Friday to hit a new 52-week low of $0.51, drifting down 1.59%.
    • Inhibikase Therapeutics (NASDAQ:IKT) stock broke to a new 52-week low of $1.65 on Friday. Shares of the company traded up 1.19%.
    • BioCardia (NASDAQ:BCDA) shares hit a yearly low of $0.39. The stock was down 0.28% on the session.
    • Addentax Group (NASDAQ:ATXG) stock hit a new 52-week low of $1.61. The stock was down 3.55% on the session.
    • Tempo Automation Holdings (NASDAQ:TMPO) stock dropped to a yearly low on Friday of $0.20. Shares traded down 2.86%.
    • ContraFect (NASDAQ:CFRX) stock hit a new 52-week low of $0.58. The stock was up 0.24% on the session.
    • Super League Enterprise (NASDAQ:SLE) shares set a new yearly low of $1.57 this morning. The stock was down 11.82% on the session.
    • Antelope Ent Hldgs (NASDAQ:AEHL) stock drifted down 6.12% on Friday morning to hit a new 52-week low of $0.30.
    • PaxMedica (NASDAQ:PXMD) shares set a new yearly low of $0.25 this morning. The stock was down 5.84% on the session.
    • ABVC BioPharma (NASDAQ:ABVC) stock hit a yearly low of $1.03. The stock was up 0.93% for the day.
    • Netcapital (NASDAQ:NCPL) stock broke to a new 52-week low of $0.42 on Friday. Shares of the company traded down 16.89%.
    • Siyata Mobile (NASDAQ:SYTA) shares reached a new 52-week low of $2.11 on Friday morning, moving down 3.77%.
    • Applied UV (NASDAQ:AUVI) shares set a new yearly low of $0.45 this morning. The stock was down 4.26% on the session.
    • Scinai Immunotherapeutics (NASDAQ:SCNI) shares fell to $0.95 on Friday, setting a new 52-week low with a shift of down 15.0%.
    • Baudax Bio (NASDAQ:BXRX) shares set a new 52-week low of $0.34. The stock traded down 2.53%.
    • RiceBran Tech (NASDAQ:RIBT) stock hit a yearly low of $0.45. The stock was down 7.16% for the day.
    • Allarity Therapeutics (NASDAQ:ALLR) shares were down 4.0% for the day, having made a 52-week low of $0.96.
    • Recruiter.Com Group (NASDAQ:RCRT) shares reached a new 52-week low of $1.42 on Friday morning, moving down 3.9%.
    • Blue Star Foods (NASDAQ:BSFC) stock set a new 52-week low of $0.35 on Friday, moving down 6.09%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $PLNT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PLNT
    $PLRX
    $PMF
    $PML

    CompanyDatePrice TargetRatingAnalyst
    CAVA Group Inc.
    $CAVA
    10/28/2025$65.00Neutral
    Mizuho
    Mister Car Wash Inc.
    $MCW
    10/27/2025$6.25Equal-Weight → Overweight
    Stephens
    Fate Therapeutics Inc.
    $FATE
    10/27/2025$7.00Neutral → Outperform
    Wedbush
    Mister Car Wash Inc.
    $MCW
    10/24/2025$6.00Overweight → Neutral
    Piper Sandler
    CAVA Group Inc.
    $CAVA
    10/22/2025$74.00 → $64.00Equal Weight
    Barclays
    SkyWater Technology Inc.
    $SKYT
    10/22/2025$25.00Buy
    Stifel
    Galapagos NV
    $GLPG
    10/22/2025$40.00Market Perform → Outperform
    Leerink Partners
    Insulet Corporation
    $PODD
    10/21/2025$370.00Buy
    Stifel
    More analyst ratings

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Imran Mir A bought $1,260,417 worth of shares (2,083,334 units at $0.60) (SEC Form 4)

    4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)

    10/27/25 7:24:25 PM ET
    $RANI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Saba Capital Management, L.P. bought $193,098 worth of shares (20,808 units at $9.28) (SEC Form 4)

    4 - Gabelli Healthcare & WellnessRx Trust (0001391437) (Issuer)

    10/27/25 7:03:55 PM ET
    $GRX
    Finance/Investors Services
    Finance

    Large owner Saba Capital Management, L.P. bought $66,677 worth of shares (7,175 units at $9.29) (SEC Form 4)

    4 - Gabelli Healthcare & WellnessRx Trust (0001391437) (Issuer)

    10/23/25 12:48:05 PM ET
    $GRX
    Finance/Investors Services
    Finance

    $PLNT
    $PLRX
    $PMF
    $PML
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on CAVA Group with a new price target

    Mizuho initiated coverage of CAVA Group with a rating of Neutral and set a new price target of $65.00

    10/28/25 8:03:12 AM ET
    $CAVA
    Restaurants
    Consumer Discretionary

    Mister Car Wash upgraded by Stephens with a new price target

    Stephens upgraded Mister Car Wash from Equal-Weight to Overweight and set a new price target of $6.25

    10/27/25 8:31:05 AM ET
    $MCW
    Automotive Aftermarket
    Consumer Discretionary

    Fate Therapeutics upgraded by Wedbush with a new price target

    Wedbush upgraded Fate Therapeutics from Neutral to Outperform and set a new price target of $7.00

    10/27/25 8:29:46 AM ET
    $FATE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Covetrus Announces Agreement for Chewy to Acquire SmartEquine

    Transaction enables Covetrus to sharpen focus on core business of delivering technology-enabled solutions for veterinarians PORTLAND, Maine, Oct. 30, 2025 /PRNewswire/ -- Covetrus®, a global animal-health technology and services company, today announced that it has entered into a definitive agreement with Chewy, Inc. (NYSE:CHWY) for Chewy to acquire the SmartEquine® business. This transaction enables Covetrus to sharpen its focus on its core business of delivering technology-enabled solutions that help veterinarians improve practice performance and patient care. By concentrati

    10/30/25 11:48:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy to Acquire SmartEquine, Expanding Leadership in the Equine Health Category

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a leader in pet food, supplies and healthcare, announced today it has entered into a definitive agreement to acquire SmartPak Equine, LLC ("SmartEquine") from Covetrus, Inc. SmartEquine, which rebranded from SmartPak in July 2025, is a leading U.S. provider of equine health products. The company is recognized for its proprietary subscription-based supplement programs, personalized nutrition plans, and broad portfolio of tack, gear, and therapeutic products designed to meet the unique needs of every horse and rider. This acquisition strengthens Chewy's position as a leader in the equine category and accelerates the company's expansion into higher-margin

    10/30/25 11:00:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

    Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") will report its third quarter 2025 financial results on Thursday, November 6, 2025. Amylyx' senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company updates. To access the conference call, please dial +1 (888) 880-3330 (U.S. & Canada) or +1 (646) 357-8766 (international) at least 10 minutes prior to the start time and ask to be joined into the Amylyx Pharmaceuticals call. A live audio webcast of the call will be available under "Events and Presentations" in the Investor section of the Company's website, https://investors.amylyx.com/events-pr

    10/30/25 9:00:00 AM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for REVUFORJ issued to SYNDAX PHARMACEUTICALS INC

    Submission status for SYNDAX PHARMACEUTICALS INC's drug REVUFORJ (ORIG-1) with active ingredient REVUMENIB has changed to 'Approval' on 11/15/2024. Application Category: NDA, Application Number: 218944, Application Classification: Type 1 - New Molecular Entity

    11/18/24 9:22:42 AM ET
    $SNDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Operating Officer Hill Stephen J.

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    10/29/25 5:42:53 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Scientific Officer Lee Gary K.

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    10/29/25 5:41:36 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by President and CEO Seely Lynn

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    10/29/25 5:40:13 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    SEC Filings

    View All

    SEC Form 10-Q filed by Bristol-Myers Squibb Company

    10-Q - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)

    10/30/25 12:04:33 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Citizens Financial Services Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CITIZENS FINANCIAL SERVICES INC (0000739421) (Filer)

    10/30/25 11:09:42 AM ET
    $CZFS
    Major Banks
    Finance

    Citizens Financial Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CITIZENS FINANCIAL SERVICES INC (0000739421) (Filer)

    10/30/25 11:08:45 AM ET
    $CZFS
    Major Banks
    Finance

    $PLNT
    $PLRX
    $PMF
    $PML
    Leadership Updates

    Live Leadership Updates

    View All

    Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155

    CAMBRIDGE, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB), a leading live biotherapeutics company, today announced that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world, will provide up to $3.6 million in additional non-dilutive funding to the Company. The grant will support development and manufacturing of an oral liquid formulation of Seres' Breakthrough Therapy designated SER-155, for medically vulnerable patient populations at risk of bloodstream infections (BSIs), including anti

    10/29/25 7:00:00 AM ET
    $MCRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

    SAN JOSE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (NASDAQ:RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the appointment of Abraham ("Abe") Bassan and Vasudev Bailey, Ph.D., to its Board of Directors. In conjunction with the new appointments, Andrew Farquharson and Maulik Nanavaty have stepped down from the Board of Directors. "We are thrilled to welcome Abe and Vasudev to our Board of Directors as we enter an exciting new era for Rani, highlighted by both our clinical-stage pipeline and expansion opportunities into high-value therapeutics from our rece

    10/23/25 4:01:45 PM ET
    $RANI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

    Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Robert ("Robbie") L. Huffines, a former Global Chair of Investment Banking at JP Morgan Chase & Co., to the Company's board of directors, effective October 31, 2025. Mr. Huffines joins the board as an independent director and will serve on the board's Audit Committee. "We are honored to welcome Robbie to Insulet's Board of Directors," said Timothy Scannell, Chairman of the Board. "Robbie brings more than three decades of distinguished experience advising healthcare companies at one of the world's leading f

    10/23/25 7:00:00 AM ET
    $PODD
    Medical/Dental Instruments
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Led to the Purchase at Aerovate Therapeutics Inc. on Jun 20?

    Recently, on June 20, 2024, a notable insider purchase was made at Aerovate Therapeutics Inc. Director Ra Capital Management, L.P. bought $1,549,944 worth of shares, acquiring 928,110 units at $1.67 per share as reported in the SEC Form 4. Insider transactions like these are closely watched by investors as they can provide valuable insights into the company's prospects. When analyzing insider transactions, it is essential to look for patterns and trends among multiple transactions to gauge the overall sentiment within the company. Several other SEC Form 4 filings were made around the same time, on June 7, 2024, by various insiders at Aerovate Therapeutics Inc. These included transactions by

    6/21/24 3:23:59 PM ET
    $AVTE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $PLNT
    $PLRX
    $PMF
    $PML
    Financials

    Live finance-specific insights

    View All

    Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

    Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") will report its third quarter 2025 financial results on Thursday, November 6, 2025. Amylyx' senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company updates. To access the conference call, please dial +1 (888) 880-3330 (U.S. & Canada) or +1 (646) 357-8766 (international) at least 10 minutes prior to the start time and ask to be joined into the Amylyx Pharmaceuticals call. A live audio webcast of the call will be available under "Events and Presentations" in the Investor section of the Company's website, https://investors.amylyx.com/events-pr

    10/30/25 9:00:00 AM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CITIZENS FINANCIAL SERVICES, INC. REPORTS UNAUDITED THIRD QUARTER 2025 FINANCIAL RESULTS

    MANSFIELD, Pa., Oct. 30, 2025 /PRNewswire/ -- Citizens Financial Services, Inc (NASDAQ:CZFS), parent company of First Citizens Community Bank (the "Bank"), released today its unaudited consolidated financial results for the three and nine months ended September 30, 2025. Highlights Net income for the first nine months of 2025 was $26,089,000, which was $6,254,000, or 31.5% more than 2024's net income through September 30, 2024 due to the increase in net interest income after the provision for credit losses of $8,920,000. The effective tax rate for the first nine months of 2025 was 18.9% compared to 17.8% in the comparable period in 2024.Net income was $10,005,000 for the three months ended

    10/30/25 8:50:00 AM ET
    $CZFS
    Major Banks
    Finance

    ZIM to Release Third Quarter 2025 Results on Thursday, November 20, 2025

    HAIFA, Israel, Oct. 30, 2025 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) announced today that the Company will release its third quarter 2025 financial results on Thursday, November 20, 2025, before the U.S. financial markets open. Management will host a conference call and webcast (along with a slide presentation) to review the results and provide a corporate update at 8:00 AM ET.   The call (and slide presentation) will be available via live webcast on ZIM's website, located at the following link. Following the conclusion of the call, a replay of the conference call will be available on the Company's website. About ZIMFounded in Israel in 1945, ZIM (NYSE:ZIM) is a lea

    10/30/25 8:00:00 AM ET
    $ZIM
    Marine Transportation
    Consumer Discretionary

    $PLNT
    $PLRX
    $PMF
    $PML
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Protara Therapeutics Inc.

    SC 13G - Protara Therapeutics, Inc. (0001359931) (Subject)

    12/17/24 4:02:03 PM ET
    $TARA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Nuveen Core Plus Impact Fund

    SC 13D/A - Nuveen Core Plus Impact Fund (0001835068) (Subject)

    12/16/24 6:56:51 PM ET
    $NPCT
    Investment Managers
    Finance

    SEC Form SC 13D filed by Prestige Wealth Inc.

    SC 13D - Prestige Wealth Inc. (0001765850) (Subject)

    12/13/24 5:00:03 PM ET
    $PWM
    Finance: Consumer Services
    Finance